Table 5.
Summary of analysis of minimum and weighted mean potassium
| UMEC treatment group | UMEC/VI treatment group | |||||
|---|---|---|---|---|---|---|
|
|
|
|||||
| Adjusted meansa | Treatment difference (90% CI) | Adjusted meansa | Treatment difference (90% CI) | |||
|
|
|
|||||
| UMEC + verapamil | UMEC | UMEC/VI + verapamil | UMEC/VI | |||
| Minimum (0–4 h) | 3.93 | 4.03 | −0.10 (−0.19, −0.01) | 3.92 | 4.05 | −0.13 (−0.23, −0.04) |
| Weighted mean (0–4 h) | 4.08 | 4.14 | −0.06 (−0.11, 0.00) | 4.04 | 4.14 | −0.10 (−0.17, −0.02) |
Note:
a
Adjusted means of potassium (0–4 hours) in mmoL/L.
Abbreviations: CI, confidence interval; UMEC, umeclidinium; VI, vilanterol.